Related references
Note: Only part of the references are listed.Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation Results From a National Primary Care Database
Hendrika A. van den Ham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
Leif Friberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in 'Low-Risk' Asian Patients With Atrial Fibrillation
Tze-Fan Chao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score
Daniel E. Singer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2012)
Moving the Tipping Point The Decision to Anticoagulate Patients With Atrial Fibrillation
Mark H. Eckman et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
Gregory Y. H. Lip et al.
EUROPACE (2011)
The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care
Kjell Asplund et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
Stroke Risk Stratification in a Real-World Elderly Anticoagulated Atrial Fibrillation Population
Daniela Poli et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke A systematic review and meta-analysis
Claire Keogh et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Jonas Bjerring Olesen et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
Antithrombotic therapy in atrial fibrillation
Daniel E. Singer et al.
CHEST (2008)
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
Margaret C. Fang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve
Nancy R. Cook
CLINICAL CHEMISTRY (2008)
Death and disability from warfarin-associated intracranial and extracranial hemorrhages
Margaret C. Fang et al.
AMERICAN JOURNAL OF MEDICINE (2007)
The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
Bjorn Wettermark et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
